Hangzhou Takeda Bio-Pharmaceutical

Hangzhou Takeda Bio-Pharmaceutical is a strategic subsidiary of Takeda Pharmaceutical Company Limited, established to bolster the parent company's presence in the Chinese market. Located in Hangzhou, China, the facility serves as a hub for manufacturing, research and development, and commercial operations within the region. The company focuses on delivering innovative therapies across Takeda's core therapeutic areas, including gastroenterology, oncology, and rare diseases. It plays a critical role in navigating the Chinese regulatory landscape and ensuring the local availability of global brands like Entyvio and Takhzyro. By integrating local insights with global expertise, Hangzhou Takeda Bio-Pharmaceutical supports the parent company's mission of providing better health and a brighter future for patients in China. The site is equipped with advanced manufacturing capabilities that adhere to international quality standards.